Abacus Life (NASDAQ:ABL – Get Free Report) is set to post its quarterly earnings results after the market closes on Thursday, November 7th. Analysts expect Abacus Life to post earnings of $0.13 per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.
Abacus Life (NASDAQ:ABL – Get Free Report) last issued its quarterly earnings data on Monday, August 12th. The company reported $0.18 earnings per share for the quarter, beating analysts’ consensus estimates of $0.13 by $0.05. Abacus Life had a positive return on equity of 7.02% and a negative net margin of 6.19%. The company had revenue of $29.08 million during the quarter, compared to analysts’ expectations of $28.57 million. During the same quarter in the previous year, the business earned $0.13 earnings per share. On average, analysts expect Abacus Life to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Abacus Life Price Performance
Shares of NASDAQ ABL opened at $8.66 on Thursday. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.59. Abacus Life has a twelve month low of $5.75 and a twelve month high of $13.25. The stock has a 50 day moving average of $9.86 and a two-hundred day moving average of $10.24. The stock has a market cap of $553.59 million, a P/E ratio of 433.00 and a beta of 0.12.
Wall Street Analyst Weigh In
Get Our Latest Report on Abacus Life
About Abacus Life
Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
Featured Articles
- Five stocks we like better than Abacus Life
- What is the S&P/TSX Index?
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- The Most Important Warren Buffett Stock for Investors: His Own
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Abacus Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus Life and related companies with MarketBeat.com's FREE daily email newsletter.